Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

FDA approves IND application for SMP-100 as treatment of IBS

May 15, 2020

Ascletis receives IND approval in China for clinical development of ASC-41 in NASH

May 14, 2020

Phase I data presented for LC51-0255

May 14, 2020

Phase III data presented on fexuprazan in patients with erosive esophagitis

May 13, 2020

Genfit reports phase III interim data on elafibranor in NASH

May 12, 2020

Ustekinumab efficacy demonstrated in pediatric Crohn's disease patients

May 12, 2020

PK and PD data presented for OPL-002 in healthy volunteers

May 12, 2020

TLR5 is a therapeutic target for treating chronic colonic hypersensibility

May 12, 2020

Genentech reports phase Ib data for UTTR-1147A

May 8, 2020

Pfizer presents phase II data for PF-06480605 in ulcerative colitis

May 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...